AB Diagnostic Systems
Private Company
Funding information not available
Overview
AB Diagnostic Systems GmbH is a privately held, commercial-stage diagnostics company headquartered in Berlin, Germany. The company leverages its 'Made in Germany' manufacturing expertise to produce a portfolio of over 60 ELISA-based diagnostic kits under its 'abia®' brand, targeting infectious diseases (HIV, hepatitis, TORCH), hormones, tumor markers, and allergies. With a 2,000 m² production facility capable of producing up to 1 million plates annually, AB Diagnostic Systems serves the global IVD market through direct offerings and OEM services, emphasizing workflow-adapted design, quality, and reliability for laboratory professionals.
Technology Platform
Optimized ELISA (Enzyme-Linked Immunosorbent Assay) platform focused on workflow-adapted design, high-quality antigen/antibody production, and scalable manufacturing of in-vitro diagnostic kits and components.
Opportunities
Risk Factors
Competitive Landscape
AB Diagnostic Systems competes in the crowded immunoassay segment against global giants like Roche, Abbott, Siemens, and bioMérieux, as well as numerous smaller specialty players. Its differentiation is based on 'Made in Germany' quality, workflow-optimized design, and a flexible business model combining branded products with OEM services.